Stock Market Manager Weekly Update: August 17th, 2022

Does your company need D & O Insurance?

Recently, a small business owner decided it was time to put a board of directors in place for his company. After several years of growth, the owner felt a board could help focus the company’s direction. Upon learning this, several people mentioned that it was prudent to get directors and officers liability insurance.

Directors, officers, and organizations are held accountable to investors and shareholders for the financial management of the company they work for. They take strategic risks for the growth of the business. Sometimes the choices they make can impact the business negatively, which can put them at risk of being sued. This insurance can be key to your business’s risk management plan.

If you are running a public company Directors and Officers Insurance could be the deciding factor in bringing on a qualified Director.

 D & O Insurance demonstrates your professionalism and ensures you’ll have protection and world class representation if you and your fellow directors are ever sued.

Get a Free Quote from a Commercial Insurance Representative in Minutes!

Click Here to fill out the on-line form

Don’t feel like filling in a form?

Skip ahead of the line and call toll-free: 405-829-6978

Weekly UpdateAugust 17th, 2022

Black Swan Connection Newsletter Signup

Breaking News

Another enormous money printing exercise with the new “INFLATION REDUCTION ACT”, which seems to be exactly the opposite. Is anyone ever going to wake up in Washington and think about how in te hell the national debt will ever be repaid ?? If global economies strengthen again in the wake of covid and the Ukraine war, we could see a very weak US $. If that happens everything we import etc become more expensive including oil.

Don’t worry though you can get a tax credit for buying a new electric vehicle with it’s battery made in China.

MarketWatch  8-17-22

Biden’s Inflation Reduction Act promises tax credits for new and used electric vehicles — here’s how to actually claim them

Your new electric car may land you a $7,500 tax credit now that the Inflation Reduction Act — designed to fight climate change and inflation — has been signed into law by President Biden.

But the new law carries certain conditions. The big change for new vehicles purchased after Aug. 16, 2022: Final assembly must take place in North America.

The federal government has outlined a list of eligible electric vehicles and provides an online portal for consumers to check exactly where their vehicle was assembled.

The electric-vehicle tax credit is one of an array of clean energy tax incentives geared at consumers and businesses within the law. Other portions of the bill include rebates and tax credits for energy efficient household systems, including solar panels, heat pumps and electric water heaters.

Check it out here

Corporate News

Sponsored by:

The 21st Century Investment Bank Capital Raises + Strategic Advisory

Donald Capital is a boutique Investment Bank that focuses on raising capital for emerging growth companies in the U.S. and around the globe.

Ideally, we like to work with Private and Public companies with a good management team, a compelling business plan, and the ability to gain market share.

For more information go to:

The Premier Operating System for Publicly Traded Companies

Track your investors’ buying and selling behaviors and use those insights to engage them across marketing channels.

Know who’s buying and selling and monitor trading in real time. Unlock your shareholders contact info and build full contact profiles on your shareholders, including emails, phone numbers, and social media accounts to engage them and target new investors through media campaigns.

Click Here For a Sequire Power Point Presentation

To schedule a demo email me at or call 727-459-7378

8-15-2022 SRAX (NASDAQ: SRAX)
SRAX Secures Revolving Credit Facility and Launches Stock Portfolio Tracker
LOS ANGELES, Aug. 15, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has announced the company has entered into a revolving credit facility and launched a website that allows investors to track the current value of the company’s marketable securities portfolio.

The revolving credit facility allows the company to draw up to $9.5M over the next 2 years. The borrowing base of the Credit Facility is determined by the company’s cash and up to 70% of the market value of the marketable securities held by the company, not to exceed $9.5M. The repayment of the Credit Facility is based on a percentage of the sales of the marketable securities from Sequire customers. The amount of the Credit Facility which is outstanding is convertible into common shares at $15 per share. It also requires the company to repurchase a minimum of $1M worth of SRAX’s stock under $5 per share.

Read Complete Release

8-15-2022 Antibe Therapeutics, Inc. (OTCQX: ATBPF Toronto: ATE.TO)
Antibe Therapeutics Reports Q1 2023 Interim Financial and Operating Results

– Phase II acute pain program to initiate in September

– Ended quarter with $50 million in cash and equivalents, providing over two years of runway

TORONTO, August 15, 2022–(BUSINESS WIRE)–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, has filed its financial and operating results for the fiscal quarter ended June 30, 2022.

“We are really pleased with our progress,” commented Dan Legault, Antibe’s CEO. “The data we’ve collected supports otenaproxesul’s target profile as a GI-safe, non-opioid oral analgesic for acute pain – a multi-billion dollar market devoid of innovation and in great need of novel therapies. We’re particularly excited to launch the Phase II molar extraction study next month, enabling us to collect data in post-operative patients for the first time. The results of this study should allow us to identify the optimal dosing regimens for the larger Phase II bunionectomy trial next year.”

Read Complete Release

7-25-2022 International Food and Beverage (OTC IFBC)
IFBC Joins SRAX Platform

PLAINVIEW, NY / ACCESSWIRE / July 25, 2022 /Italian Food & Beverage Corp. (OTC Pink:IFBC) Is pleased to announce that it has joined the SRAX Premier Operating System for Publicly Traded Companies. The benefits to IFBC from this arrangement extend from the fostering of the IFBC brand to potential investors, to creating an awareness of IFBC and its products to beverage distribution companies and other marketing channels across the entire USA. SRAXInc. is a NASDAQ company, which, by way of its sophisticated financial technology, unlocks valuable data and insightful nuances of the shareholder bases for publicly traded companies. With its premier investor intelligence and communications platform, Sequire, through which companies can carefully track their investors’ behaviors, trends, and patterns, and use those insights to engage current and potential investors across a host of marketing channels.

Read Complete Release

07-26-2022 CanB Corp (OTC  CANB)
Can B Corp. Inks Manufacturing & Distribution Agreement for Superfood Products with Forever Brands and Brooke Burke via BB Body, Inc.

Initial 3-Year Worldwide Agreement

HICKSVILLE, NY, July 26, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products and other wellness products and programs, is pleased to announce the signing of a Manufacturing and Distribution Agreement with Forever Brands to produce a line of nutritional Superfoods drink mix for Brooke Burke and her company, BB Body, Inc.

The initial 3-year worldwide agreement covers the sale, manufacturing and distribution of the Superfood and related nutritional products. Can B subsidiaries Imbibe Wellness Solutions is the exclusive direct to consumer seller of the products and Pure Health Products is a manufacturer and distributor of the products. The products will be marketed under the Longevity by Brooke Burke trademarks and brand. The partnership includes a powdered drink superfood mix, all-natural metabolic energy drink and other products that may be mutually agreed from time to time.

Read Complete Release

7-8-2022 Antibe Therapeutics, Inc. (OTCQX: ATBPF Toronto: ATE.TO)
Phase 2 Post-Operative Pain Program to Initiate in Calendar 4Q22…

Business Update

Phase 2 Post-Operative Pain Program to Initiate in Calendar 4Q22
Antibe Therapeutics, Inc. (OTC:ATBPF) (TSX:ATE.TO) is developing otenaproxesul as a solution to the dose-related gastrointestinal (GI) side effects associated with non-steroidal anti-inflammatory drugs (NSAIDs). It uses naproxen as a base molecule with a hydrogen sulfide moiety covalently attached. Hydrogen sulfide (H2S) is an important gasotransmitter, which is a gas that serves as an important signaling molecule in the body.

The company is developing otenaproxesul for the management of acute pain, with an initial indication of post-operative pain. The most recent pharmacokinetic/pharmacodynamic (PK/PD) study conducted by Antibe examined various loading doses of otenaproxesul. The results from this study suggests that the drug has a potentially rapid onset of action that would be necessary for an acute pain treatment.

Read Complete Release

6-6-2022 SRAX (NASDAQ: SRAX)

SRAX Reports Record Full Year and Q4 2021 Financial Results
LOS ANGELES, June 06, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, is providing full year financial results.

SRAX exceeded guidance of $31.5M for 2021, with SRAX totaling $28.6 million in revenue, and its former subsidiary, BIGtoken, totaling $3.4 million in revenue. Due to the deconsolidation of BIGtoken as of December 31, 2021, the following full year earnings report includes BIGtoken’s results from operations as discontinued operations. Due to an increase in bookings, SRAX is providing guidance of $47M-$50M for 2022.

Read Complete Release

5-31- 2022 Ecrid, Inc  (OTC ECDD)
ECRID/ResMac Mortgage Strikes Deal That Can Change the Entire Credit Industry

PALM BEACH, FL , May 31, 2022 /PRNewswire/ — ECRID, Inc. (Stock Symbol: ECDD) and ResMac Mortgage have teamed up to help millions of Americans become home owners who have difficulty obtaining mortgages or refinancing existing mortgages in this current economic climate. ECRID, the new Credit Bureau offers the tools and resources to assist Americans in taking control of their financial destinies to become financially stable and build wealth. Through the ECRID platform customers can sign up and create their own ECRID Credit Report and Apply for a Mortgage through ECRID Lending Corp. and begin their journey to financial health.

Read Complete Release

5-17-2022 Coeptis Therapeutics, Inc. OTC COEP

Coeptis Therapeutics Enters into Exclusive Option Agreement with University of Pittsburgh for Rights to CAR-T Technologies Designed to Target Multiple Cancer Indications, Including Hematologic and Solid Tumors

WEXFORD, Pa., May 17, 2022 /PRNewswire/ — Coeptis Therapeutics, Inc. (OTC PINK: COEP) (“Coeptis” or “the Company”), a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announced entry into an exclusive option agreement with the University of Pittsburgh for the rights to three chimeric antigen receptor T cell (CAR-T) technologies that offer the potential to address a range of hematologic and solid tumors. Among the initial cancer indications under development are pre-clinical programs targeting breast cancer and ovarian cancer. Terms of the deal were not disclosed.

The exclusive option agreement involves the intellectual property rights to three technologies jointly developed in the laboratories of Jason Lohmueller, Ph.D., Assistant Professor of Immunology; Alexander Deiters, Ph.D., Professor of Chemistry; and Olivera Finn, Ph.D., Professor of Immunology: 1) mSA2 affinity-enhanced biotin-binding CAR, 2) universal self-labeling SynNotch and CARs for programable antigen-targeting, and 3) conditional control of universal CAR-T cells through stimulus-reactive adaptors. Per the option agreement, Coeptis paid the University of Pittsburgh a non-refundable fee for the exclusive option to license the patent rights to each of the three technologies. Coeptis has until October 29, 2022, to exercise the options and pay the specified exercise considerations. The option agreement may be extended an additional six months, subject to the agreement of both parties.

Read Complete Press Release

Alternative Investments-

Check out our latest commercial properties including an Amazing Private Island or Resort Development Property in Panama

3700 Acre Private Island in the Las Perlas Islands

7.4 Acre beachfront paradise for development or private retreat

Message me on Linkedin and check our latest commercial listings:

Please subscribe to our newsletter to get ongoing Real Estate and Alternative Investing updates:

Black Swan Connection Newsletter Signup

August 17, 2022
Coeptis Therapeutics, Inc. Ecrid, Inc (ECDD)   Profile        
Antibe Therapeutics, Inc (ATBPF)  Profile 11/11/2018 News
Can B Corp (CANB) Profile News
Endurance Exploration Group, Ltd (EXPL)  Profile   03-26/19 News
Social Reality, Inc. (SRAX) Profile News
International Food and Beverage   Profile        

July 27, 2022
ValuEngine Weekly Report

Best Performing ETF’s Year-to-Date 2022

July 27, 2022 by Herb Blank

The list of best performing equity ETFs in the US thus far this year has been dominated by two categories: 1. Leveraged/Inverse – almost always the case by definition and 2. Single industry/sector – including energy, utilities, defense, and insurance et al.  Leveraged and inverse ETFs are short-term trading tools that are very rarely, if at all, suitable for most investors. Because these two categories are so inappropriate for many investors, what to do? Low volatility and high dividend yield funds have out performed as well and are readily accessible.

Read Complete Report

ValuEngine new strategies, Podcast introduction

ValuEngine Capital Management LLC (VECM) is pleased to announce the addition of Jordan Kimmel to the team as the new Chief Equity Strategist and portfolio manager. VECM is a Registered Investment Advisor (RIA) that invests based on the proprietary, quantitative research produced by ValuEngine Inc. It is an important partnership between two companies: ValuEngine conducts research, and ValuEngine Capital Management LLC actively trades client funds using this research.



To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

Want to learn more about ValuEngine? Our methods? Our history? 
Check out our video presentation HERE

SMM Research Partners

Black Swan Research Coverage and Subscription Service
Click Here>>

Event Calendar Updates

NIBA is back

Register Now for NIBA’s Upcoming Florida Conference

September 7-8, 2022

At the luxurious Margaritaville Hollywood Beach Resort in Hollywood, Florida
Register Now to Present, Attend and Sponsor
NIBA’s upcoming Florida Conference is a one-and-a-half day fast-paced, intimate event that provides private and public issuers, regardless of size or industry, a unique platform to present their individuals stories to prospective investors, financing partners, market makers and market professionals, all experienced within the capital markets.
The 2022 LD Micro Invitational, Hosted by SRAX, Featured Many Influential Companies – Replays Available

LOS ANGELES, June 16, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, hosted the 2022 LD Micro Invitational, both in-person in Westlake Village, CA and virtually via their Sequire Virtual Events platform, on June 7th-9th. The conference featured 187 companies, presenting for 25 minutes each. Replays are now available for viewing.

For Replays Click Here

Rocky Mountain Microcap Conference IX.

The conference was a good success with great attendance and a recap will be available soon.

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

-SMM Distribution Update-

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)          520

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Pages                 (contacts)                          1,100

SMM Youtube Channel            (followers)                                 6 

SMM Instagram Page  *          (followers)                               11

Direct Email     *                                                          220,000

Total                                                                           256,460

Black Swan Connection Newsletter Signup